Take pathogen testing to the next level
By
Now available in Europe, IRIDICA, the pioneering infectious test platform from global healthcare company Abbott, has the potential to change how pathogens are detected and identified, and may help reduce the use of broad-spectrum antibiotics, a leading cause of antibiotic resistance.